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Abstract
Objective—To evaluate the relationship between birth weight (along with a variety of pre- and 
perinatal characteristics) and the risk of pediatric Hodgkin lymphoma (HL) diagnosed at age <20 
years.
Method—We linked California statewide birth records from 1978-2009 and cancer diagnosis data 
from 1988-2011 to conduct a population-based case-control study with 1,216 cases and 4,485 
controls (matched on birth month and year, sex, and race/ethnicity). Conditional logistic regression 
was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI) of pediatric HL 
overall and by age of diagnosis, controlling for other perinatal factors.
Results—Compared to children with a normal birth weight (2,500-3,999 g), those who had a 
high birth weight (≥ 4000 g) had an increased risk of pediatric HL overall (OR=1.23, 95% CI: 
1.02-1.48) after adjusting for birth order, maternal age at the time of delivery, and paternal age at 
the time of delivery. The magnitude of association appeared larger for subgroups of children 
whose age of diagnosis was 0-10 years (OR=1.56, 95% CI: 1.04-2.24) or 15-19 years (OR=1.43, 
95% CI: 1.11-1.83), while no association was observed in 11-14 year olds. Compared to firstborn 
children, those who were third or higher in birth order had a reduced risk of pediatric HL overall 
(OR=0.80, 95% CI: 0.67-0.95), and this association also varied by age of diagnosis.
Conclusions—In this study with the largest number of pediatric HL cases, high birth weight was 
associated with an increased disease risk for most but not all ages of diagnosis. The different 
Corresponding author: Xiaomei Ma, PhD, Yale School of Public Health, PO Box 208034, 60 College Street, New Haven, CT 
06520-8034, United States, Xiaomei.ma@yale.edu, Phone: (203) 785-3880, Fax: (203) 785-6980.
*Mr. Triebwasser and Dr. Wang contributed equally.
Conflict of Interest Disclosures: None.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Eur J Cancer. Author manuscript; available in PMC 2017 December 01.
Published in final edited form as:













findings by age of diagnosis regarding both birth weight and birth order underscore the importance 
to stratify pediatric HL by age at diagnosis in future etiological investigations.
Introduction
In the United States (US), Hodgkin lymphoma (HL) is the third most common malignancy 
diagnosed in the pediatric population (age 0-19 years), with an estimated number of 1,140 
new cases in 2014.1 While HL accounts for only 4% of cancer diagnosed in children 0-14 
years of age (with an incidence of 0.6 cases per 100,000 person-years), it represents about 
15% of cancer diagnoses in adolescents 15-19 years, with an incidence of 3.0 cases per 
100,000 person-years.1,2 Although survival rates are now extremely high due to improved 
treatments, pediatric HL survivors retain elevated risks of treatment-related morbidities over 
the long term, which can severely impact quality of life.3 Although infection with Epstein-
Barr virus is an established risk factors for HL,4,5 much of the etiology of pediatric HL is 
still obscure, and research in this area remains a priority.
Recent epidemiologic investigations have evaluated various perinatal characteristics for 
possible associations with pediatric HL. In particular, birth weight has been assessed in 
several of these studies as a potential marker for intrauterine growth, with inconsistent 
results. Multiple studies6-13 and a meta-analysis published in 201214 found no association 
between birth weight and risk of pediatric HL. However, a large birth cohort study from 
Sweden observed a significant positive association between increasing birth weight and risk 
of HL diagnosed at the age of 0-37 years and reported no heterogeneity by age of diagnosis 
(0-14 years versus 15-37 years).15
Due to the rarity of pediatric HL, most existing studies included a relatively small number of 
cases and likely had suboptimal statistical power. The number of HL cases in the studies 
included in the meta-analysis14 ranged from 84 to 474, while the Swedish birth cohort study 
included 943 HL cases. In addition, different studies focused on different age ranges, with 
many restricted to HL cases diagnosed at the age of 0-14 years.6-8,10,12,13
Given the high incidence of HL at the age of 15-19 years1 and the lack of consensus on the 
relation of birth weight to HL risk, we conducted a population-based case-control study with 
an unprecedented sample size to clarify the role of birth weight in the etiology of HL over 
the entire pediatric age range (i.e., 0-19 years).
Method
Study Design
This study was based on a population-based linkage of California statewide birth records 
from 1978-2009 (maintained by the Vital Statistics Division of the California Department of 
Public Health) and cancer diagnosis data from 1988-2011 (collected by the California 
Cancer Registry). Histologically confirmed cases of pediatric HL (aged 0-19 years at the 
time of diagnosis) were identified using information reported to the California Cancer 
Registry. For each case, up to four controls were randomly sampled from statewide birth 
records and individually matched to each case on birth month and year, sex, and race/
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ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian/Pacific Islander, and 
other). Record linkage and the selection of cases and controls were performed by research 
staff at the California Cancer Registry. The study protocol was approved by the Institutional 
Review Boards of California Health and Human Services and all participating academic 
institutions (Yale University, University of California, Berkeley, and University of 
California, San Francisco).
Study Population
The initial study population consisted of 1,323 pediatric HL cases and 5,292 matched 
controls. In order to preserve data quality, we excluded individuals with missing or unknown 
values for at least one of the following variables: birth weight, birth order, maternal age at 
the time of delivery, maternal birthplace, and delivery method (vaginal or cesarean). As a 
result, a total of 7 cases and 78 controls were excluded. We further excluded one case and 
one control whose birth weight was outside a plausible range (350g - 5,999g), as well as 98 
cases and 377 controls whose gestational age was outside a plausible range (20 - 44 weeks). 
Finally, one case without matched controls was excluded, so were 315 controls without 
matched cases, resulting in a final study population of 1,216 pediatric HL cases and 4,485 
matched controls.
Variables of Interest
Data on birth weight, as well as various other infant, maternal, and paternal characteristics 
were obtained from birth records. Based on data available in birth records, we considered the 
following variables as potential confounders of the relation between birth weight and risk of 
pediatric HL: gestational age, birth order, plurality, maternal age at delivery, maternal 
birthplace, maternal education level, paternal age at delivery, paternal education level, 
delivery method, maternal history of diabetes, maternal history of pregnancy loss (defined as 
history of miscarriage and/or stillbirth), and proportion of the population living in poverty in 
the zip code of the mother's residence at time of delivery (as a proxy for socioeconomic 
status). Additional information about the diagnosis of pediatric HL, including the age at 
diagnosis and histological subtype, was obtained from the California Cancer Registry.
Statistical Analysis
Infant and parental characteristics were categorized and compared between cases and 
controls using Pearson's Chi-square test. To evaluate the association between birth weight 
and risk of pediatric HL, multivariable conditional logistic regression models (conditioned 
on matching factors of birth month and year, sex, and race/ethnicity) were used to estimate 
odds ratios 8 and 95% confidence intervals 16. We examined birth weight, the primary 
exposure of interest, as both a categorical and continuous variable. For categorical analysis, 
birth weights were defined as low birth weight (<2,500g), normal birth weight (2,500g - 
3,999g), and high birth weight (≥4,000g). For the multivariable analysis, the initial model 
included gestational age (20-36 weeks, 37-41 weeks, or 42-44 weeks), birth order (1st, 2nd, 
or 3rd and higher), plurality (singleton versus multiple birth), maternal age the time of 
delivery (<20, 20-24, 25-29, 30-34, or ≥35 years), maternal birthplace (foreign- versus US-
born), maternal education level (12th grade or less, more than 12th grade, or unknown), 
paternal age at the time of delivery (<20, 20-24, 25-29, 30-34, ≥35 years, or unknown), 
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paternal education level (12th grade or less, more than 12th grade, or unknown), delivery 
method (vaginal versus cesarean), maternal history of diabetes (yes versus no), maternal 
history of pregnancy loss (yes versus no), and the proportion of the population living in 
poverty within the zip code of the mother's residence at the time of delivery (<5%, 5-9%, 
10-19%, ≥20%, or unknown). After a stepwise selection using SAS (version 9.4, SAS 
Institute, Inc., Cary, North Carolina), the final model evaluating the association between 
birth weight and risk of overall pediatric HL adjusted for birth order, maternal age at the 
time of delivery, and paternal age at the time of delivery.
We further evaluated the relationship between birth weight and risk of pediatric HL stratified 
by age at diagnosis (0-10, 11-14, and 15-19 years), sex, histological subtype (nodular 
sclerosis and mixed cellularity), and race/ethnicity (non-Hispanic white, non-Hispanic black, 
Hispanic, and Asian/Pacific Islander). The cut-off points for age at diagnosis were chosen 
based on two considerations: (1) age-specific incidence of HL in California; and (2) number 
of cases available in each subgroup. The histological subtype of HL was classified using the 
International Classification of Diseases for Oncology (3rd edition, ICD-O-3) codes17: 
nodular sclerosis (ICD-O-3 codes: 9661, 9663-7), mixed cellularity (ICD-O-3 code 9652), 
and other (ICD-O-3 codes: 9650, 9651, 9653-5, 9659). Within each subgroup analysis, 
covariates in the final model were also obtained using stepwise selection procedures. 
Therefore, the sets of covariates included in the final models for different subgroup analyses 
varied.
We also conducted a confirmatory analysis in which unconditional logistic regression 
models were performed that included the matching factors as well as all other covariates 
described above. All significance tests were two-sided with an α-level of 0.05. All analyses 
were conducted using SAS (version 9.4, SAS Institute, Inc.).
Results
Of the 1,216 pediatric HL cases included in the study, the majority (56%) were male, and 
53% were diagnosed at 15-19 years of age (Table 1, Figure 1a). Based on an unadjusted 
bivariate analysis, cases were significantly heavier at birth than controls, with 14.8% of 
cases having a high birth weight compared to 12.1% of controls. When modeled as a 
function of birth order via LOESS (local polynomial regression), cases were also generally 
expected to be heavier than controls (Figure 1b). Maternal and paternal ages were also 
significantly higher for cases than controls. (p<0.01 for both) (Table 1). In addition, cases 
were more likely to be delivered by cesarean section (25% for cases compared to 22% for 
controls; p=0.04). The remaining characteristics were similar between cases and controls 
(Table 1).
Based on the final multivariable conditional logistic regression model (Table 2), compared to 
normal birth weight, high birth weight was positively associated with the risk of pediatric 
HL (OR=1.23, 95% CI: 1.02-1.48). When birth weight was modeled as a continuous 
variable, a 1,000g increase in birth weight was associated with a 16% increase in risk of 
pediatric HL (95% CI: 1.03-1.30). Compared with firstborn children, those who were third 
or higher in birth order had a significantly reduced risk of pediatric HL (OR=0.80, 95% CI: 
Triebwasser et al. Page 4













0.67-0.95). There was also suggestion that younger parental age was associated with a 
reduced risk of pediatric HL in the overall study population: compared with the age-group of 
25-29 years, a maternal age < 25 years or a paternal age of 20-24 years was associated with 
a lower risk of HL (Table 2).
In further analyses evaluating the relationship between birth weight and pediatric HL in 
specific diagnostic age ranges (Tables 2-3), significant positive associations for high birth 
weight and risk of HL were observed among those diagnosed at 0-10 years (OR=1.56, 95% 
CI: 1.04-2.34) or 15-19 years (OR=1.43, 95% CI: 1.11-1.83). No significant association was 
observed for the age group of 11-14 years. Within the age group of 15-19 years, low birth 
weight was significantly associated with a 44% decrease in odds of HL (OR=0.56, 95% CI: 
0.36-0.89), an association which was absent in the overall study population (Tables 2-3). In 
addition, the association between birth order and risk of HL also varied by age of diagnosis, 
in that a significant association was observed among those diagnosed at 15-19 years 
(OR=0.66, 95% CI: 0.52-0.84), but not among those diagnosed at 0-10 years or 11-14 years 
(Table 2).
Additional stratified analyses revealed that high birth weight was significantly associated 
with increased disease risk among males (OR=1.26, 95% CI: 1.00-1.59) or the histological 
subtype of nodular sclerosis (OR=1.26, 95% CI: 1.02-1.57), but not among females or those 
with mixed cellularity subtype (Table 3). High birth weight was not associated with 
increased risk of HL in any of the subgroups defined by race/ethnicity. However, low birth 
weight was associated with decreased risk of HL in non-Hispanic whites (OR=0.46, 95% CI: 
0.24-0.89) and increased risk of HL among Asian/Pacific Islanders (OR=3.10, 95% CI: 
1.19-8.11) (Table 3).
Results from the confirmatory analysis using unconditional logistic regression were 
consistent with the findings from conditional logistic regression models (detailed data not 
presented).
Discussion
In this large population-based study, we found that high birth weight was associated with an 
increased risk of pediatric HL. Additionally, having a birth order of third or higher 
(compared to being the firstborn) conferred a significant protective effect. However, these 
effects were not consistent across subgroups defined by age of diagnosis, sex, histological 
subtype, and race/ethnicity.
In our study, the association between birth weight and HL risk was similar in the age groups 
of 0-10 years and 15-19 years, while the association between birth order and HL risk was 
only observed in 15-19 year olds. It is possible that HL diagnosed at different ages may have 
distinct etiologies. HL incidence varies by age, following a bimodal age distribution with 
peaks at 15-34 years and greater than 60 years.18 It has been proposed that age of diagnosis 
may be associated with the etiologic profile of HL and that those diagnosed under the age of 
10 years should be considered separately from those diagnosed at 15-34 years.19
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While the OR for high birth weight was elevated for both males and females, the association 
only reached statistical significance in males in our study. This was similar to the 
observation of Milne et al., who utilized proportion of optimal birth weight (POBW) as a 
metric for appropriateness of fetal growth20 and found that a higher POBW was associated 
with an increased risk of childhood HL (age 0-14 years) in boys but not girls.21 A majority 
of cases in our study population were classified as nodular sclerosis based on histology, and 
the relationship between birth weight and risk of pediatric HL in this subgroup mirrored the 
results from the overall population. As the histological subtype of mixed cellularity is much 
rarer, we were unable to assess whether the apparent absence of association between birth 
weight and this subtype was due to small sample size and limited power, versus any possible 
difference in etiology. Subgroup analyses by race/ethnicity generally showed an elevated OR 
for high birth weight (with the exception of Asians/Pacific Islanders), but all confidence 
intervals included 1. Given the small number of subjects who were non-Hispanic black or 
Asian/Pacific Islander, results derived from these two groups should be interpreted with 
caution.
It has been proposed that high birth weight (as marker for accelerated fetal growth) may be 
related to risk of pediatric cancers via biological mechanisms involving elevated levels of 
insulin-like growth factors that may be implicated in carcinogenesis.22 Although high birth 
weight has been implicated as a risk factor for several other types of pediatric cancer, such 
as leukemia, neuroblastoma, brain tumors (astrocytoma and medulloblastoma), and Wilms' 
tumor,23-27 the role of birth weight in the etiology of pediatric HL has been inconsistent. The 
positive association between high birth weight and risk of HL had previously been reported 
to be similar in cases diagnosed at 0-14 years and 15-37 years.15 Milne et al. found that a 
higher POBW was associated with an increased risk of childhood HL (age 0-14 years) in 
boys.21 Aside from these studies, the majority of published studies evaluating birth weight 
and risk of HL in pediatric populations have reported null findings,6-14 and most of those 
studies included only cases diagnosed at the age of 0-14 years.6-8,10,12,13 In our study, when 
we analyzed the age of 0-14 years as one single group, we did not find any significant 
association between HL and birth weight (measured either categorically or continuously), 
which was consistent with most previous studies. The differing risk profiles observed in our 
study between cases diagnosed at ages 0-10 years and those diagnosed at ages 11-14 years 
suggest that the age grouping of 0-14 years used in many previous studies may be too broad. 
In future epidemiological research of pediatric HL, it is probably important to consider age 
of diagnosis as a potential marker for distinct underlying etiology.
Our results pointed to a decreased risk of pediatric HL for those with a birth order of third or 
higher. A study evaluating HL risk in a young adult population (aged 15-39 years at the time 
of diagnosis) identified a protective effect for higher birth order relative to those born third 
or earlier.28 Another study reported significantly different risk patterns for birth order 
between childhood (<15 years) and young adult (≥15 years) populations, such that higher 
birth order appeared to decrease risk of HL in the young adult population and (non-
significantly) increase risk of HL in children under 15 years.29 These differing risk patterns 
for birth order and risk of HL between childhood and young adult populations are 
particularly noteworthy in the context of our results. Subgroup analyses of our data revealed 
that birth order was only a significant predictor in those aged 15-19 years. As such, the 
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effect of birth order on risk of HL may be modified by age at diagnosis. This observation 
may be related to infectious origins of HL due to Epstein-Barr virus (EBV) or other agents, 
under which those with a delayed exposure to infections have a higher risk of HL, and those 
with earlier exposure to infectious agents via contact with older siblings have a reduced 
risk.28,30 Alternatively, a higher incidence of HL in the age group of 15-19 years may have 
simply offered an improved statistical power to detect an association, if one truly exists.
Our study has several important strengths. Population-based record linkage in a state as 
populous as California gave rise to a large number of pediatric HL cases relative to earlier 
studies, and presented a significant advantage in terms of statistical power. A record-based 
study without the need to trace or consent any subjects minimized concerns of selection bias. 
Additionally, data on exposure of interest, potential confounders, and disease outcome were 
obtained exclusively from preexisting records, which minimized potential for information 
bias.
In light of these noted advantages, there were also limitations to our study. In particular, we 
were limited to data available in existing records, and therefore could not adjust for 
additional possible risk factors for pediatric HL such as maternal smoking during 
pregnancy31 and history of -EBV- infection or infectious mononucleosis.32,33 Interestingly, a 
recent study conducted by the Children's Oncology Group reported that fewer than 24% of 
childhood HL cases (age 0-14 years) had EBV-positive tumor, and there did not appear to be 
systematic differences in risk factors by EBV status.34 In addition, we did adjust for a 
number of other potential confounder based on information contained in birth records, and 
we excluded individuals with missing or improbable values for important variables in order 
to ensure high data quality. Approximately 7% of subjects were excluded due to implausible 
values in birth weight or gestational age. To evaluate the impact of such exclusions, we 
repeated all analyses without excluding these subjects, and the results were essentially the 
same (data not shown). Furthermore, despite the fact that our study included more pediatric 
HL cases than any other previous studies, the sample sizes for some of the subgroup 
analyses were small, preventing us from drawing more definitive conclusions. The relatively 
long period for case ascertainment (1988-2011) was also a potential weakness, due to 
possible temporal changes in classification systems and cancer reporting. On the other hand, 
the incidence rate of pediatric HL has remained stable in California over the study period. 
When we conducted additional analyses by including year of diagnosis as a covariate and by 
stratifying the study population by different eras of diagnosis (1988-1999 versus 
2000-2011), there was barely any change in the results. Finally, it is possible that some cases 
were not captured by the California Cancer Registry as a result of moving out of California 
or incomplete case ascertainment, and some control patients may have been misclassified. 
However, under the extreme assumption that all controls were lost to follow-up, based on the 
age-adjusted incidence rates of pediatric HL (age 0-19 years) in the US over the study 
period,2 only fewer than two incident cases of HL would have arisen from the 4,485 
controls, had they been followed through their 20th birthday. As such, the potential for bias 
due to misclassification of the disease outcome was minimal.
In conclusion, this study provides evidence for a positive association between high birth 
weight and risk of pediatric HL. The different findings by age of diagnosis with regard to 
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both birth weight and birth order suggest that it may be important to stratify pediatric HL by 
age at diagnosis in future etiological investigations.
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In this large population-based study, we found that pediatric Hodgkin lymphomas 
diagnosed at different ages might have distinct etiological profiles.
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Figure 1a. Age of cases at time of pediatric HL diagnosis
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Figure 1b. Local regression (LOESS) predictions for birth weight according to birth order by 
case/control status
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Table 2
Factors associated with risk of pediatric Hodgkin lymphoma
Characteristics Odds ratio* (95% confidence interval) p-value
Overall; ages 0-19 years (1216 cases/4485 controls)
 Birth weight (in grams)
  Low (<2500) 0.79 (0.58, 1.07) 0.13
  Normal (2500-3999) Reference
  High (≥4000) 1.23 (1.02, 1.48) 0.03
  Per 1,000g increase 1.16 (1.03, 1.30) 0.01
 Birth Order
  1st Reference
  2nd 1.02 (0.87, 1.19) 0.79
  3rd or higher 0.80 (0.67, 0.95) 0.01
 Maternal Age at Delivery (in years)
  <20 0.66 (0.48, 0.89) <0.01
  20-24 0.73 (0.60, 0.88) <0.01
  25-29 Reference
  30-34 1.03 (0.86, 1.24) 0.76
  ≥35 0.94 (0.73, 1.21) 0.63
 Paternal Age at Delivery (in years)
  <20 0.99 (0.66, 1.51) 0.98
  20-24 0.76 (0.61, 0.95) 0.02
  25-29 Reference
  30-34 0.94 (0.78, 1.14) 0.54
  ≥35 1.22 (0.98, 1.52) 0.08
  Unknown 0.90 (0.63, 1.28) 0.56
Ages 0-10 years (241 cases/904 controls)
 Birth weight (in grams)
  Low (<2500) 0.64 (0.28, 1.44) 0.28
  Normal (2500-3999) Reference
  High (≥4000) 1.56 (1.04, 2.34) 0.03
  Per 1,000g increase 1.28 (0.97, 1.69) 0.08
 Maternal education level
  12th grade or less Reference
  More than 12th grade 1.14 (0.75, 1.71) 0.54
  Unknown 15.64 (1.71, 142.6) 0.01
Ages 11-14 years (326 cases/1196 controls)
 Birth weight (in grams)
  Low (<2500) 1.40 (0.83, 2.37) 0.21
  Normal (2500-3999) Reference
  High (≥4000) 0.81 (0.55, 1.20) 0.30
  Per 1,000g increase 0.87 (0.70, 1.09) 0.22
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Characteristics Odds ratio* (95% confidence interval) p-value
 Maternal Birthplace
  United States 1.00 (Reference)
  Foreign 1.52 (1.10, 2.10) 0.01
 % population living in poverty (by zip code)
  <5% 0.66 (0.41, 1.06) 0.08
  5-9% 0.90 (0.64, 1.27) 0.54
  10-19% Reference
  ≥20% 0.86 (0.59, 1.25) 0.43
  Unknown 0.20 (0.06, 0.67) 0.01
Ages 15-19 years (649 cases/2385 controls)
 Birth weight (in grams)
  Low (<2500) 0.56 (0.36, 0.89) 0.01
  Normal (2500-3999) Reference
  High (≥4000) 1.43 (1.11, 1.83) <0.01
  Per 1,000g increase 1.33 (1.13, 1.57) <0.01
 Birth Order
  1st Reference
  2nd 0.96 (0.77, 1.19) 0.69
  3rd or higher 0.66 (0.52, 0.84) <0.01
 Maternal Age at Delivery (in years)
  <20 0.48 (0.30, 0.76) <0.01
  20-24 0.67 (0.51, 0.87) <0.01
  25-29 Reference
  30-34 1.01 (0.78, 1.31) 0.93
  ≥35 0.90 (0.63, 1.29) 0.57
 Maternal education level
  12th grade or less Reference
  More than 12th grade 0.90 (0.67, 1.23) 0.51
  Unknown 1.23 (0.37, 4.06) 0.74
 Paternal Age at Delivery (in years)
  <20 0.99 (0.51, 1.93) 0.98
  20-24 0.69 (0.51, 0.95) 0.02
  25-29 Reference
  30-34 0.93 (0.72, 1.20) 0.57
  ≥35 1.37 (1.02, 1.84) 0.04
  Unknown 0.72 (0.41, 1.25) 0.24
 % population living in poverty (by zip code)
  <5% 1.30 (0.97, 1.75) 0.08
  5-9% 0.84 (0.64, 1.09) 0.18
  10-19% Reference
  ≥20% 1.01 (0.76, 1.35) 0.94
  Unknown 0.82 (0.47, 1.44) 0.49
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*
Odds ratios were derived from multivariable stepwise conditional logistic regression; all variables in the model were mutually adjusted for each 
other.











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Eur J Cancer. Author manuscript; available in PMC 2017 December 01.
